BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

JW Therapeutics' supplemental license application for Carteyva® in relapsed or refractory Mantle Cell Lymphoma has been accepted by the NMPA.

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immun...

January 05, 2024 | News

Turn Biotechnologies Unveils Enhanced eTurna™ Platform to Address Industry's Delivery Challenges

Company announces development of novel ionizable lipids and stabilizing components eTurna™ delivery platform expected to improve safety, redu...

January 04, 2024 | News

Atal Incubation Centre - CCMB and Thermo Fisher Scientific Join Forces to Drive Innovation in Startup Ecosystem

At the heart of this partnership lies the establishment of a cutting-edge laboratory, outfitted with state-of-the-art, high-end equipment generously provid...

January 03, 2024 | News

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...

December 29, 2023 | News

Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024

Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...

December 29, 2023 | News

FDA Grants Orphan Drug Designation to Boan Biotech's Two Novel Claudin 18.2 Drugs.

Orphan drugs, also known as drugs for rare diseases, are drugs for preventing, treating or diagnosing rare diseases. Being designated as orphan drugs will ...

December 28, 2023 | News

Nectin Therapeutics Expands Clinical Trial to Israel, Progresses Swiftly

Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology t...

December 27, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

December 22, 2023 | News

Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore

Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...

December 22, 2023 | News

CellOrigin Treats First CAR-M Patient in China, Unveils Second-Gen CAR-M for Solid Tumors

"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...

December 21, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

December 19, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

Biotech and Biopharma Industry Trends: What to Watch for in 2024

In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...

December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific

Crown Aesthetics Reveals Groundbreaking Study on BIOJUVE™ Skin Microbiome-Optimized Regimen

Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced that its groundbreaking clinical study, recently accepted for publication i...

December 14, 2023 | News

Stay Connected